학술논문
Cost-effectiveness of second-line vasopressors for the treatment of septic shock
Document Type
Article
Author
Source
Journal of Critical Care; February 2020, Vol. 55 Issue: 1 p48-55, 8p
Subject
Language
ISSN
08839441
Abstract
To determine the cost-effectiveness of escalating doses of norepinephrine or norepinephrine plus the adjunctive use of vasopressin or angiotensin II as a second-line vasopressor for septic shock.